VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $43,213,000 | -57.5% | 3,917,812 | -44.0% | 0.19% | -58.2% |
Q4 2016 | $101,644,000 | -43.8% | 7,000,303 | -5.0% | 0.44% | -43.5% |
Q3 2016 | $180,816,000 | +22.9% | 7,365,210 | +0.8% | 0.79% | +21.6% |
Q2 2016 | $147,118,000 | -22.7% | 7,304,762 | +0.9% | 0.65% | -23.0% |
Q1 2016 | $190,421,000 | -50.5% | 7,240,337 | +91.3% | 0.84% | -47.5% |
Q4 2015 | $384,645,000 | +42.9% | 3,784,012 | +150.7% | 1.60% | +43.8% |
Q3 2015 | $269,197,000 | -31.2% | 1,509,122 | -14.4% | 1.12% | -18.5% |
Q2 2015 | $391,481,000 | +5.0% | 1,762,238 | -6.1% | 1.37% | +7.9% |
Q1 2015 | $372,817,000 | -25.7% | 1,877,040 | -46.5% | 1.27% | -21.8% |
Q4 2014 | $502,053,000 | +8.4% | 3,508,163 | -0.6% | 1.62% | +12.9% |
Q3 2014 | $463,013,000 | +16.4% | 3,529,237 | +11.9% | 1.44% | +21.6% |
Q2 2014 | $397,815,000 | +11.0% | 3,153,748 | +16.0% | 1.18% | +19.9% |
Q1 2014 | $358,335,000 | +3029.6% | 2,718,162 | +2686.9% | 0.99% | +3425.0% |
Q4 2013 | $11,450,000 | -5.0% | 97,534 | -15.6% | 0.03% | -9.7% |
Q3 2013 | $12,055,000 | +5.6% | 115,544 | -12.8% | 0.03% | +6.9% |
Q2 2013 | $11,412,000 | – | 132,579 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |